NHLBI
Research and Policy Update
Number 7
July 2004
This
electronic distribution list will provide updates from the
NHLBI Web Site for the research community. The Updates will be
sent as needed, but no more than once a week.
Funding Updates
RFA-HL-05-004: Novel Targets
and Therapy Development for Ischemic Stroke
Receipt
Dates: Letter of Intent, December 10, 2004
Application,
January 11, 2005
RFA-HD-04-020:
Prevention and Treatment of Childhood Obesity in Primary Care
Settings
Receipt
Dates: Letter of Intent, October 25, 2004
Application,
November 23, 2004
RFA-HL-04-031:
Mechanisms of HIV-Related Pulmonary Complications
Receipt
Dates: Letter of Intent, February 17, 2005
Application,
March 16, 2005
RFP
NHLBI-HR-05-04: Clinical Centers for a Clinical Research Network
for the Treatment of Acute Lung Injury & Acute Respiratory Distress
Syndrome
Receipt
Dates: Letter of Intent, August 27, 2004
Application,
October 8, 2004
PA-04-126:
Supplements to Promote Reentry into Biomedical and Behavioral
Research Careers
PA-04-125: Novel Approaches to
Enhance Animal Stem Cell Research
PA-04-121: Understanding Mechanisms
of Health Risk Behavior Change in Children and Adolescents
For
additional initiatives, please visit the following Web page:
NHLBI Grants and Contracts
page
Policy Updates
Investigator-Initiated
Epidemiology (Non-Clinical Trial, Non-Intervention) Studies Guidelines
For
additional policy documents, please visit Funding
/ Award Policy section on the following Web
page:
Funding, Training, and Policies
Training Updates
Minority/Disability
Trainee Positions on NRSA Training Grants (T32)--Instructions
for Applicants
For
more information on training and career development programs,
please visit the following Web page:
Training and Career Development
Meetings
List
of upcoming meetings
National
Heart, Lung, and Blood Advisory Council, September 2-3, 2004
Symposium
on Cardiovascular Regenerative Medicine, September 13-14,
2004
AHA/NHLBI
3rd Annual Workshop on Cardiovascular Interventional MRI,
November 8, 2004
For
more information on upcoming meetings, please visit the following
Web page:
Announcements of NHLBI Meetings,
Conferences, and Events
Reports
of past meetings
Myocardial
Protection at a Crossroads:The Need for Translation Into Clinical
Therapy (Circulation Research. 2004;95:125.) -- Report of
the NHLBI Working Group Meeting: Translation of Therapies for
Protecting the Heart from Ischemia, June 2003
Frontiers of Knowledge in Sleep & Sleep Disorders: Opportunities
for Improving Health and Quality of Life, Conference Summary,
March 2004
Needs
and Opportunities to Study Hypersensitivity Pneumonitis, NHLBI
Working Group Executive Summary, May 2004
Lung
Allograft Transplantation: New Science and Clinical Advances,
Working Group Executive Summary, June 2004
For more information
on past meetings, please visit the following Web page:
Workshop and Meeting Summaries,
and Other Scientific Reports
Press Releases
Update
on Cholesterol Guidelines: More-Intensive Treatment Options for
Higher Risk Patients, July 12, 2004
For
additional Press Releases, please visit the following Web page:
Current Press Releases
Selected NHLBI Vacancies
There
are no selected vacancies currently posted on the NHLBI site,
however, there are often changes and additions to this list. For
the most current information, please visit the NHLBI
Jobs Opportunities page
Other Items of Interest
NHLBI
Sponsored Course: Genetic Approaches to Complex Heart, Lung, and
Blood Diseases
This intensive, 9-day course is designed for the young investigator
just beginning her/his career or the more established investigator
wishing to move in a new direction. Emphasis is placed on how
to characterize gene function using the latest in biochemical
and molecular genetic techniques. Application deadline: August
9, 2004
ATP
III Update 2004: Implications of Recent Clinical Trials for the
ATP III Guidelines
Since the publication of ATP III, 5 major clinical trials of statin
therapy with clinical end points have been published. These trials
addressed issues that were not examined in previous clinical trials
of cholesterol-lowering therapy. The present document reviews
the results of these recent trials and assesses their implications
for cholesterol management.
Fifth
Annual Public Interest Organization Meeting (Summary), February
2004
The National Heart, Lung, and Blood Institute (NHLBI) convened
its fifth annual public interest organization meeting to encourage
and promote public input and involvement in Institute activities.
Approximately 130 individuals participated in the 1-day meeting.
They included members of more than 65 public interest organizations,
as well as representatives from professional societies, voluntary
health agencies, the NHLBI, and the National Heart, Lung, and
Blood Advisory Council (NHLBAC).
From
Public Advocacy To Research Priorities, NHLBI Listens And Responds
The booklet provides a brief history of how the NHLBI has worked with public interest organizations over the years to develop and support research programs to address a wide range of diseases.
An
Archive of the current and past issues
is available on the NHLBI Web site.
Two
ways to unsubscribe:
- Send an e-mail message to: LISTSERV@LIST.NIH.GOV
and, in the text of your message (not the subject line), write
(or copy/paste):
SIGNOFF NHLBI-RESEARCH-POLICY-L
- Use the List Web Page
A) select
this link
B) Enter your e-mail address as it appears in the To: field
of the list,
C) Enter your full name, and
D) Select the button, Leave the list.
|